{
    "2018-12-11": [
        [
            {
                "time": "",
                "original_text": "【平安】行业专题报告*生物医药*样本医院整体增长乏力，抗肿瘤靶向药崛起引领结构变迁*强于大市",
                "features": {
                    "keywords": [
                        "生物医药",
                        "样本医院",
                        "增长乏力",
                        "抗肿瘤靶向药",
                        "结构变迁"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：聚焦优势赛道 荐10股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "优势赛道",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：公司产品未在“4+7城市药品集采试点方案”集采名单中，目前对公司未产生影响",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "4+7城市药品集采",
                        "未产生影响"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "28家药企40天计划减持1.93亿股",
                "features": {
                    "keywords": [
                        "药企",
                        "减持",
                        "1.93亿股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}